Credit Suisse have IDL rated outperform with a target of $1.75 yet we languish around $1.20.Is the S/P being manipulate for a hidden agenda??
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025